Viveka Roychowdhury

Will new IP policy ensure Sabka Vikas?

Read more

Finding the hidden gems

Read more

Balancing the scales

Read more

TC Biopharm to start phase II/III studies of ImmuniCell in October

Read more

The Journey From Cow to Consumption

Read more

Mainstreaming AYUSH

Read more

The journey from cow to consumption

Read more

Playing for high stakes

Read more

TC Biopharm to start phase II/III studies of ImmuniCell in October

Read more

Mylan’s One Quality Standard a long way off

Read more